Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

SMi's Asthma & COPD conference next week in London

SMi Group
Posted on: 05 Apr 18
SMi's Asthma & COPD conference next week in London

SMi Group reports: Limited availability on Managers Special Discount

 

Last call [Managers Special offer - £500 savings] on SMi's Asthma & COPD conference, taking place on 11 – 12 April in London - to Directors, Principle scientists, Senior scientists, Associate directors, Managing directors, Medical directors, Pharmaceutical experts, Group leaders, Inhalation toxicologists of: clinical pharmacology; respiratory medicine/ science; respiratory immunology; pulmonary specialty; respiratory physiology.

 

Organisers are glad to welcome Richard Marsden, Chief Executive Officer of Synairgen to the speaker line-up on the Day 1 of the event

 

Event in programme in brief:

April 11 (Day 1) will have presentations covering: 

Novel approaches to management and prevention of COPD exacerbations (Wisla Wedzicha of Imperial College London); 

Development of inhaled interferon beta for the treatment and/or prevention of virus-induced exacerbations of Asthma and COPD (Richard Marsden, Chief Executive Officer, Synairgen);

Adherence to inhaled therapy - the challenges and opportunities of digital technologies (Richard Costello, Professor, Royal College of Surgeons in Ireland); 

Regulatory requirements, human factors and usability for inhaled drug- device combination products (Quan Yang, Pharmaceutical Assessor, MHRA). 

In addition - a number of other exciting presentations covering Novel Therapeutic Approaches to COPD & Asthma and Advancements in Inhalation Device Development. 

April 12 (Day 2) will cover topics of:

Genetic Driven Drug Discovery for Respiratory Disease (Jonathan Phillips, Principal Scientist, Inflammation, Amgen);

New Therapeutic Targets for COPD (Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart & Lung Institute);

From efficacy to effectiveness, the Salford lung study in COPD and now asthma (David Leather, Medical Vice President, Global Respiratory Franchise, GSK)

In addition - multiple presentations on the following areas: Early Detection - Molecular Phenotyping and Biomarker Development, Real World Studies and Disease Modifying Drugs and The Emerging Role of Smooth Muscle in Asthma.

To secure £500 Managers Special Discount* register your interest at http://www.asthma-copd.co.uk/pharmiweb or contact Kieran Ronaldson on +44 (0)20 7827 6744 / kronaldson@smi-online.co.uk
 

Event is sponsored by: Vitalograph

 

Contact:

+44 (0)20 7827 6000

ldurneva@smi-online.co.uk

 

STAY CONNECTED

LinkedIn – search 'SMi Pharma'

Twitter – @SMIpharm and #AsthmaCOPDsmi

 

Asthma & COPD | 11 - 12 April 2018 | Copthorne Tara Hotel, London, UK

http://www.asthma-copd.co.uk/pharmiweb    

For more information:
www.asthma-copd.co.uk/pharmiweb    

Editor's Details

Durneva
SMi Group
www.asthma-copd.co.uk/pharmiweb    
LDurneva@smi-online.co.uk

Last updated on: 05/04/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.